Holdings of ACORN CAPITAL ADVISORS, LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 19 in 1 countries
- Top ten
- 92.7 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Terns Pharmaceuticals Inc | 1,746,264 | 92.1M $ | |
| 2 | CG oncology Inc | 1,130,501 | 76.6M $ | |
| 3 | Puma Biotechnology Inc | 4,131,299 | 26.4M $ | |
| 4 | Trevi Therapeutics Inc | 2,144,844 | 25.6M $ | |
| 5 | Candel Therapeutics Inc | 3,497,948 | 17.2M $ | |
| 6 | Bicara Therapeutics Inc | 643,382 | 12.8M $ | |
| 7 | OnKure Therapeutics Inc | 2,839,674 | 11.8M $ | |
| 8 | JADE BIOSCIENCES INC | 786,760 | 11.1M $ | |
| 9 | Protara Therapeutics Inc | 1,752,115 | 9.1M $ | |
| 10 | Verastem Inc | 1,469,153 | 7.8M $ | |
| 11 | LeonaBio Inc | 634,539 | 6.5M $ | |
| 12 | Aura Biosciences Inc | 595,744 | 4M $ | |
| 13 | Aadi Bioscience Inc | 1,139,363 | 3.9M $ | |
| 14 | Cardiff Oncology Inc | 1,762,084 | 2.9M $ | |
| 15 | Q32 Bio Inc | 315,052 | 2M $ | |
| 16 | Karyopharm Therapeutics Inc | 287,826 | 1.6M $ | |
| 17 | JASPER THERAPEUTICS INC | 1,411,492 | 1.2M $ | |
| 18 | BIOATLA INC | 5,406,345 | 865K $ | |
| 19 | VYNE THERAPEUTICS INC | 1,425 | 855 $ |
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 19 | 313.4M $ | 100.00 % |
Cite this page
Titelia. "Holdings of ACORN CAPITAL ADVISORS, LLC". https://titelia.com/en/funds/US13F2054410